Petros Pharmaceuticals, Inc. (PTPI) SEC Filings — 2024
19 SEC filings for Petros Pharmaceuticals, Inc. (PTPI) in 2024.
Filings
- Petros Pharma 8-K: Financial Obligation Trigger Event — 8-K · Dec 16, 2024
- Petros Pharmaceuticals Files 8-K on Shareholder Votes — 8-K · Nov 21, 2024
- Petros Pharma Files Supplemental Proxy for Nov 20 Meeting — DEFA14A · Nov 18, 2024
- Petros Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Petros Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- Petros Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
- Petros Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Oct 25, 2024
- Petros Pharma Board & Executive Changes Announced — 8-K · Oct 18, 2024
- Petros Pharmaceuticals Files 8-K for Material Agreement — 8-K · Oct 17, 2024
- Petros Pharma Appoints New CMO, Elects Director — 8-K · Oct 4, 2024
- Petros Pharma Files 8-K on Shareholder Nominations — 8-K · Sep 19, 2024
- Petros Pharma Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
- Petros Pharma Files 2023 Annual Report Amendment — 10-K/A · May 31, 2024
- Petros Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- Petros Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
- Petros Pharmaceuticals Enters Material Definitive Agreement — 8-K · Mar 22, 2024
- Petros Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
- Intracoastal Capital, Kopin Report 4.9% Stake in Petros Pharma — SC 13G/A · Feb 6, 2024
- Petros Pharma Changes Certifying Accountant, Effective Jan 8 — 8-K · Jan 12, 2024